{
  "meta": {
    "title": "27_Histamine_Serotonin_Lipid_Autacoid",
    "url": "https://brainandscalpel.vercel.app/27-histamine-serotonin-lipid-autacoid-33a36663.html",
    "scrapedAt": "2025-11-30T06:59:50.814Z"
  },
  "questions": [
    {
      "id": 83882,
      "choices": [
        {
          "id": 247914,
          "text": "Treatment of these patients with erythromycin, a macrolide antibiotic"
        },
        {
          "id": 247915,
          "text": "Use of these drugs by addicts"
        },
        {
          "id": 247916,
          "text": "Genetic predisposition to metabolize succinylcholine slowly"
        },
        {
          "id": 247917,
          "text": "Concurrent treatment with phenobarbital"
        }
      ],
      "text": "Two antihistaminics ,Terfenadine and astemizole were withdrawn from the market following the occurrence of cardiac arrhythmias when they were present in high levels in the blood. These effects were explained by the fact.",
      "unique_key": "Q1887230",
      "question_audio": null,
      "question_video": null,
      "map_id": 34650763,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Treatment of these patients with erythromycin, a macrolide antibiotic Terfenadine and astemizole are non-sedating second-generation H1-antihistamines that were withdrawn from the market due to their proarrhythmic effects, including QT prolongation and torsades de pointes (TdP). These drugs require hepatic metabolism via the cytochrome P450 (CYP3A4) enzyme to be converted into their inactive metabolites. When CYP3A4 is inhibited by drugs such as erythromycin (a macrolide antibiotic), these antihistamines accumulate in the blood, leading to potent blockade of cardiac K+ channels (hERG channels), which can result in dangerous ventricular arrhythmias. Because erythromycin is a known CYP3A4 inhibitor, its co-administration with terfenadine or astemizole led to increased plasma drug levels, explaining why these drugs were withdrawn from the market. Incorrect Options: (B) Use of these drugs by addicts – Incorrect. The withdrawal of terfenadine and astemizole was due to their pharmacokinetic interactions with CYP3A4 inhibitors, not because of misuse or abuse by addicts. These drugs do not have psychoactive or addictive properties, making this option irrelevant to their withdrawal. (C) Genetic predisposition to metabolize succinylcholine slowly – Incorrect. Succinylcholine is a neuromuscular blocking agent that is metabolized by plasma cholinesterase, not CYP3A4. A genetic deficiency in plasma cholinesterase can lead to prolonged paralysis with succinylcholine use, but this has no relation to the cardiac arrhythmias caused by terfenadine and astemizole. (D) Concurrent treatment with phenobarbital – Incorrect. Phenobarbital is a CYP3A4 inducer, meaning it would increase the metabolism of terfenadine and astemizole, reducing their plasma levels rather than increasing them. This would likely decrease the risk of arrhythmias, not contribute to it.",
      "correct_choice_id": 247914,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67262641700220054/67262641700220054.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/67262641700220054/67262641700220054.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83883,
      "choices": [
        {
          "id": 247918,
          "text": "Common cold"
        },
        {
          "id": 247919,
          "text": "Dermographism"
        },
        {
          "id": 247920,
          "text": "Insect bite"
        },
        {
          "id": 247921,
          "text": "Seasonal hay fever"
        }
      ],
      "text": "H1 antihistaminics afford benefit in a number of conditions. All of the following conditions are benefited by antagonism of histamine EXCEPT",
      "unique_key": "Q8317281",
      "question_audio": null,
      "question_video": null,
      "map_id": 34236381,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Common cold H1-antihistamines are effective in conditions where histamine plays a key role, such as allergic reactions, urticaria, and insect bites. However, in the common cold, the primary cause of symptoms like nasal congestion and rhinorrhea is due to viral infection, not histamine release. While some first-generation H1-antihistamines (e.g., diphenhydramine, chlorpheniramine) can provide symptomatic relief by causing sedation and drying secretions, they do not directly target the underlying viral infection or inflammatory mediators like bradykinin and prostaglandins, which play a major role in cold symptoms. Thus, the benefit of H1-antihistamines in the common cold is minimal and indirect, making this the correct choice for the exception. Incorrect Options: (B) Dermographism – Incorrect. Dermographism (skin writing) is a form of physical urticaria, where histamine release leads to raised, itchy welts on the skin after mechanical stimulation. H1-antihistamines are the first-line treatment because they block histamine receptors, reducing swelling, redness, and itching. (C) Insect bite – Incorrect. Insect bites trigger localized histamine release, leading to itching, redness, and swelling. H1-antihistamines are effective in reducing these allergic and inflammatory reactions by blocking histamine receptors. (D) Seasonal hay fever – Incorrect. Seasonal hay fever (allergic rhinitis) is caused by histamine release in response to allergens (e.g., pollen), leading to symptoms like sneezing, nasal congestion, and watery eyes. H1-antihistamines are commonly used to relieve these allergic symptoms.",
      "correct_choice_id": 247918,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45262381700220065/45262381700220065.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45262381700220065/45262381700220065.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83884,
      "choices": [
        {
          "id": 247922,
          "text": "Granisetron"
        },
        {
          "id": 247923,
          "text": "Ranitidine"
        },
        {
          "id": 247924,
          "text": "Sumatriptan"
        },
        {
          "id": 247925,
          "text": "Adrenaline"
        }
      ],
      "text": "Which of the following can reverse one or more smooth muscle effects of circulating histamine in humans",
      "unique_key": "Q3106552",
      "question_audio": null,
      "question_video": null,
      "map_id": 34846949,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Adrenaline Adrenaline (epinephrine) is the most effective agent for reversing the smooth muscle effects of circulating histamine in humans. It acts by stimulating α and β adrenergic receptors, leading to bronchodilation, vasoconstriction, and inhibition of further histamine release from mast cells. This makes adrenaline the drug of choice in anaphylaxis, where excessive histamine release causes severe bronchoconstriction, vasodilation, and hypotension. The ability of adrenaline to counteract histamine-induced effects is the reason it is the correct answer. Incorrect Options: (A) Granisetron – Incorrect. Granisetron is a 5-HT3 receptor antagonist, primarily used as an antiemetic to prevent nausea and vomiting associated with chemotherapy. It has no role in reversing histamine-induced smooth muscle effects. (B) Ranitidine – Incorrect. Ranitidine is an H2 receptor antagonist that reduces gastric acid secretion by blocking histamine’s action on parietal cells. However, it does not counteract histamine’s smooth muscle effects on the bronchi or blood vessels, making it ineffective in conditions like anaphylaxis or bronchospasm. (C) Sumatriptan – Incorrect. Sumatriptan is a 5-HT1B/1D agonist used for treating migraines. It causes vasoconstriction of cranial blood vessels but does not have any significant action on histamine-induced smooth muscle effects.",
      "correct_choice_id": 247925,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34077151700220076/34077151700220076.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34077151700220076/34077151700220076.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83885,
      "choices": [
        {
          "id": 247926,
          "text": "Alprostadil"
        },
        {
          "id": 247927,
          "text": "Epoprostenol"
        },
        {
          "id": 247928,
          "text": "Latanoprost"
        },
        {
          "id": 247929,
          "text": "Misoprostol"
        }
      ],
      "text": "Drug that can be used to prevent platelet aggregation and damage during hemodialysis or cardiopulmonary bypass is",
      "unique_key": "Q4136567",
      "question_audio": null,
      "question_video": null,
      "map_id": 34855876,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Epoprostenol Epoprostenol is a prostacyclin (PGI2) that acts as a potent vasodilator and inhibitor of platelet aggregation. It is commonly used during hemodialysis and cardiopulmonary bypass to prevent platelet activation, which can lead to clot formation in extracorporeal circuits. Epoprostenol works by increasing cyclic adenosine monophosphate (cAMP) levels in platelets, leading to reduced aggregation and thrombus formation. Additionally, it has a short half-life, making it ideal for continuous infusion in such clinical settings. Its ability to prevent clot formation without causing excessive bleeding makes it the preferred choice in these scenarios. Incorrect Options: (A) Alprostadil: Alprostadil is a prostaglandin E1 (PGE1) analog primarily used for treating erectile dysfunction and maintaining ductus arteriosus patency in neonates with congenital heart defects. While it has vasodilatory properties, it is not commonly used for preventing platelet aggregation in hemodialysis or cardiopulmonary bypass. (C) Latanoprost: Latanoprost is a prostaglandin F2α (PGF2α) analog used to treat glaucoma by increasing aqueous humor outflow and reducing intraocular pressure. It does not have significant effects on platelet function or clot prevention, making it irrelevant to the given context. (D) Misoprostol: Misoprostol is a prostaglandin E1 (PGE1) analog used mainly for preventing NSAID-induced gastric ulcers and inducing labor. While it has some vasodilatory effects, it lacks the specific antiplatelet and anticoagulant properties required for use in hemodialysis or cardiopulmonary bypass.",
      "correct_choice_id": 247927,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45685801700221174/45685801700221174.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/45685801700221174/45685801700221174.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83886,
      "choices": [
        {
          "id": 247930,
          "text": "5HT1B/1D Receptor Agonists"
        },
        {
          "id": 247931,
          "text": "5HT2B Receptor Agonists"
        },
        {
          "id": 247932,
          "text": "5HT1A Receptor Agonists"
        },
        {
          "id": 247933,
          "text": "5HT2C Receptor Agonists"
        }
      ],
      "text": "Lorcarserin is a",
      "unique_key": "Q3770065",
      "question_audio": null,
      "question_video": null,
      "map_id": 34173585,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) 5HT2C Receptor Agonist Lorcaserin is a selective 5HT2C receptor agonist primarily used as an anti-obesity drug. It acts on serotonin (5HT2C) receptors in the hypothalamus, specifically in the pro-opiomelanocortin (POMC) neurons, to promote satiety and reduce food intake. By activating these receptors, lorcaserin enhances the release of melanocortin, which helps suppress appetite, leading to weight loss. Importantly, it has a high selectivity for 5HT2C over 5HT2B receptors, reducing the risk of cardiac valvulopathy, a side effect associated with earlier serotonergic weight-loss drugs. Incorrect Options: (A) 5HT1B/1D Receptor Agonists: These receptors are primarily involved in vasoconstriction and play a crucial role in the mechanism of triptans, which are used for migraine treatment. Drugs like sumatriptan target 5HT1B/1D receptors to relieve migraines by constricting cranial blood vessels. Lorcaserin does not act on these receptors and has no role in migraine therapy. (B) 5HT2B Receptor Agonists: Activation of 5HT2B receptors is linked to cardiac valvular disease, as seen with drugs like fenfluramine. Lorcaserin is specifically designed to avoid 5HT2B activation, making it safer for long-term use. (C) 5HT1A Receptor Agonists: The 5HT1A receptor is primarily involved in mood regulation and anxiety. Drugs like buspirone and certain antidepressants target this receptor to exert anxiolytic and antidepressant effects. Lorcaserin does not significantly act on 5HT1A receptors and is not used for mood disorders.",
      "correct_choice_id": 247933,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63140571700221188/63140571700221188.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/63140571700221188/63140571700221188.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83887,
      "choices": [
        {
          "id": 247934,
          "text": "Fexofenadine"
        },
        {
          "id": 247935,
          "text": "Epinastine"
        },
        {
          "id": 247936,
          "text": "Azelastine"
        },
        {
          "id": 247937,
          "text": "Emedastine"
        }
      ],
      "text": "Which of the following antihistamine has both H1 and H2 antagonist activity",
      "unique_key": "Q2456257",
      "question_audio": null,
      "question_video": null,
      "map_id": 34174156,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Epinastine Epinastine is a unique antihistamine that exhibits both H1 and H1 receptor antagonist activity. It is primarily used as an ophthalmic solution for treating allergic conjunctivitis. As an H1 receptor antagonist, it blocks histamine-mediated allergic responses, such as itching and inflammation. Additionally, its H1 receptor blocking action helps reduce vascular permeability and inflammation, further controlling allergic reactions. Unlike many other antihistamines, epinastine has a dual mechanism that provides a broader spectrum of action against allergic conditions. Moreover, it has minimal penetration into the central nervous system (CNS), reducing the risk of sedation, a common side effect of first-generation antihistamines. Incorrect Options: (A) Fexofenadine: Fexofenadine is a selective H1 receptor antagonist that does not exhibit H1 receptor blockade. It is a second-generation antihistamine commonly used for allergic rhinitis and chronic urticaria, offering non-sedating effects due to its minimal CNS penetration. However, it does not have any significant action on H1 receptors. (C) Azelastine: Azelastine is a potent H1 receptor antagonist with additional mast cell-stabilizing properties. It is often used as a nasal spray or ophthalmic solution to treat allergic rhinitis and conjunctivitis. Although it has anti-inflammatory effects beyond H1 receptor antagonism, it does not significantly block H1 receptors. (D) Emedastine: Emedastine is a selective H1 receptor antagonist used in ophthalmic preparations for allergic conjunctivitis. It does not have H1 receptor-blocking properties and is primarily effective in counteracting the histamine effects mediated by H1 receptor activation.",
      "correct_choice_id": 247935,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62589751700221202/62589751700221202.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/62589751700221202/62589751700221202.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83888,
      "choices": [
        {
          "id": 247938,
          "text": "Fab fragment toward IL-1"
        },
        {
          "id": 247939,
          "text": "Fab fragment toward IL-6"
        },
        {
          "id": 247940,
          "text": "Fab fragment toward TNF-alpha"
        },
        {
          "id": 247941,
          "text": "Fab fragment toward Nerve growth factor"
        }
      ],
      "text": "Certolizumab is a",
      "unique_key": "Q7324853",
      "question_audio": null,
      "question_video": null,
      "map_id": 34125792,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Fab fragment toward TNF-alpha Certolizumab is a humanized monoclonal antibody fragment (Fab) directed against tumor necrosis factor-alpha (TNF-α). It lacks the Fc region, which reduces its ability to cause complement activation or antibody-dependent cellular cytotoxicity (ADCC), thereby minimizing immune-related side effects. Certolizumab binds to TNF-α and neutralizes its inflammatory effects, making it an effective treatment for autoimmune diseases such as rheumatoid arthritis, Crohn’s disease, and psoriatic arthritis. Its pegylated formulation increases its half-life, allowing for less frequent dosing compared to other TNF-α inhibitors. Incorrect Options: (A) Fab fragment toward IL-1: Interleukin-1 (IL-1) inhibitors, such as Anakinra, target IL-1 to reduce inflammation in conditions like rheumatoid arthritis and autoinflammatory syndromes. However, Certolizumab specifically targets TNF-α and does not interfere with IL-1 pathways. (B) Fab fragment toward IL-6: IL-6 inhibitors, such as Tocilizumab, block the IL-6 pathway to treat inflammatory diseases like rheumatoid arthritis. Certolizumab does not act on IL-6 and has no role in IL-6-mediated immune responses. (D) Fab fragment toward Nerve Growth Factor (NGF): NGF inhibitors, such as Tanezumab, are being studied for their role in pain management by blocking nerve growth factor signaling. Certolizumab does not target NGF and is not used in pain-related conditions that involve NGF pathways.",
      "correct_choice_id": 247940,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19637401700221215/19637401700221215.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/19637401700221215/19637401700221215.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83889,
      "choices": [
        {
          "id": 247942,
          "text": "CGRP receptor antagonist"
        },
        {
          "id": 247943,
          "text": "Kallikrein antagonist"
        },
        {
          "id": 247944,
          "text": "Serotonin 1F agonist"
        },
        {
          "id": 247945,
          "text": "Bradykinnin receptor agonist"
        }
      ],
      "text": "Aprotinin is a",
      "unique_key": "Q7029424",
      "question_audio": null,
      "question_video": null,
      "map_id": 34491517,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Kallikrein antagonist Aprotinin is a kallikrein inhibitor, meaning it inhibits plasma kallikrein, an enzyme involved in the kinin-kallikrein system. By doing so, aprotinin reduces the activation of bradykinin, which is responsible for increasing vascular permeability and promoting inflammation. Aprotinin also has antifibrinolytic properties, as it inhibits plasmin, trypsin, and other proteolytic enzymes. Because of these effects, aprotinin has been used in cardiac surgery (e.g., coronary artery bypass grafting) to reduce bleeding and the need for blood transfusions. However, due to concerns over increased thrombotic risks, its use has been restricted in many countries. Incorrect Options: (A) CGRP receptor antagonist: Aprotinin is not a CGRP receptor antagonist. CGRP (Calcitonin Gene-Related Peptide) receptor antagonists, such as ubrogepant and rimegepant, are used in the treatment of migraine by blocking CGRP-mediated vasodilation and pain transmission. Aprotinin has no role in CGRP-related pathways. (C) Serotonin 1F agonist: Aprotinin does not act on serotonin (5-HT) receptors. Serotonin 1F (5-HT?F) agonists, such as lasmiditan, are used in the treatment of acute migraine by inhibiting neuronal inflammation without causing vasoconstriction. Aprotinin has no serotoninergic activity. (D) Bradykinin receptor agonist: Aprotinin is the opposite of a bradykinin receptor agonist. Instead of activating bradykinin receptors, it inhibits kallikrein, reducing bradykinin production and its effects on vasodilation, pain, and inflammation. Drugs that act as bradykinin receptor agonists, such as bradykinin itself, can cause hypotension and increased vascular permeability, which is not the action of aprotinin.",
      "correct_choice_id": 247943,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76165201700221593/76165201700221593.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/76165201700221593/76165201700221593.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83890,
      "choices": [
        {
          "id": 247946,
          "text": "5-HT1"
        },
        {
          "id": 247947,
          "text": "5-HT3"
        },
        {
          "id": 247948,
          "text": "5-HT2"
        },
        {
          "id": 247949,
          "text": "5-HT4"
        }
      ],
      "text": "All 5-HT receptors are heptahelical serpentine receptors EXCEPT",
      "unique_key": "Q5373381",
      "question_audio": null,
      "question_video": null,
      "map_id": 34573076,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) 5-HT3 The 5-HT3 receptor is unique among serotonin (5-HT) receptors because it is not a G-protein coupled receptor (GPCR). Instead, it is a ligand-gated ion channel, specifically a pentameric cation channel that belongs to the Cys-loop receptor family, similar to nicotinic acetylcholine receptors and GABA_A receptors. When serotonin binds to 5-HT3 receptors, it directly opens the ion channel, allowing Na+ and Ca2+ influx, leading to rapid depolarization and neuronal excitation. This receptor is primarily found in the central nervous system (CNS) and the enteric nervous system, playing a significant role in nausea, vomiting, and pain perception. The fact that 5-HT3 is an ionotropic receptor rather than a metabotropic receptor (like other serotonin receptors) makes it the correct answer. Incorrect Options: (A) 5-HT1: The 5-HT1 receptor family (including 5-HT1A, 5-HT1B, etc.) consists of G-protein coupled receptors (GPCRs) that work through Gi/o proteins, leading to inhibition of adenylate cyclase, reduced cAMP production, and overall inhibitory effects on neurotransmission. These are classic heptahelical serpentine receptors. (C) 5-HT2: The 5-HT2 receptor family (5-HT2A, 5-HT2B, 5-HT2C) consists of GPCRs that couple with Gq proteins, leading to activation of phospholipase C (PLC), increased IP3 and DAG production, and intracellular calcium release, resulting in excitatory effects. These are also heptahelical serpentine receptors. (D) 5-HT4: The 5-HT4 receptor is a GPCR that couples with Gs proteins, leading to stimulation of adenylate cyclase and increased cAMP levels, which enhances neurotransmission. Like other GPCRs, it has a seven-transmembrane (heptahelical) domain structure.",
      "correct_choice_id": 247947,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42531591700221691/42531591700221691.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/42531591700221691/42531591700221691.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83891,
      "choices": [
        {
          "id": 247950,
          "text": "These do not impair psychomotor performance"
        },
        {
          "id": 247951,
          "text": "They lack anticholinergic actions"
        },
        {
          "id": 247952,
          "text": "These may possess additional antiallergic mechanisms"
        },
        {
          "id": 247953,
          "text": "These possess high anti-motion sickness activity"
        }
      ],
      "text": "All of the following statements are TRUE about second generation antihistaminic agents EXCEPT",
      "unique_key": "Q1565906",
      "question_audio": null,
      "question_video": null,
      "map_id": 34073021,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) These possess high anti-motion sickness activity Second-generation antihistamines do not have significant anti-motion sickness activity because they do not readily cross the blood-brain barrier (BBB) and therefore do not strongly block central H? receptors. Motion sickness is primarily mediated by the vestibular system in the brainstem, where first-generation antihistamines (e.g., diphenhydramine, promethazine, meclizine) are effective due to their central H? and anticholinergic effects. Since second-generation antihistamines lack central sedative and anticholinergic properties, they are ineffective for motion sickness, making this statement incorrect. Incorrect Options (True Statements): (A) These do not impair psychomotor performance: This is true because second-generation antihistamines, such as loratadine, cetirizine, and fexofenadine, have poor CNS penetration and therefore do not cause significant sedation or impair psychomotor function. This is a key advantage over first-generation antihistamines, which cause drowsiness and cognitive impairment. (B) They lack anticholinergic actions: This is true because second-generation antihistamines are selective for peripheral H? receptors and do not block muscarinic receptors, unlike first-generation antihistamines (e.g., diphenhydramine, chlorpheniramine), which have anticholinergic side effects such as dry mouth, blurred vision, and urinary retention. (C) These may possess additional antiallergic mechanisms: This is true because some second-generation antihistamines, such as cetirizine, also have anti-inflammatory and mast cell-stabilizing properties, which can help reduce allergic inflammation beyond simple H? receptor blockade. This makes them more effective for long-term allergy control.",
      "correct_choice_id": 247953,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18192651700221725/18192651700221725.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/18192651700221725/18192651700221725.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83892,
      "choices": [
        {
          "id": 247954,
          "text": "Consuming processed cheese"
        },
        {
          "id": 247955,
          "text": "Strenous physical exertion"
        },
        {
          "id": 247956,
          "text": "Driving motor vehicles"
        },
        {
          "id": 247957,
          "text": "All of the above"
        }
      ],
      "text": "Mr. Surya Kant was prescribed a first generation antihistaminic drug. He should be advised to avoid",
      "unique_key": "Q3315635",
      "question_audio": null,
      "question_video": null,
      "map_id": 34659500,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Driving motor vehicles First-generation antihistamines, such as diphenhydramine, chlorpheniramine, promethazine, and hydroxyzine, are known to cross the blood-brain barrier (BBB) and cause significant sedation and drowsiness due to central H? receptor blockade. These drugs can impair alertness, coordination, and reaction times, increasing the risk of accidents and injuries while driving or operating heavy machinery. Therefore, patients taking first-generation antihistamines should be advised to avoid driving motor vehicles, as it can be dangerous due to their psychomotor impairing effects. Incorrect Options: (A) Consuming processed cheese: There is no significant interaction between first-generation antihistamines and processed cheese. However, MAO inhibitors (e.g., phenelzine, tranylcypromine) can interact with tyramine-rich foods like cheese, leading to hypertensive crises—but this is not relevant to antihistamines. (B) Strenuous physical exertion: First-generation antihistamines do not directly interfere with physical exertion. However, in rare cases, excessive sedation may reduce physical performance. This is not a major concern compared to the risk of impaired driving. (D) All of the above: Since only driving motor vehicles is a major safety concern, this option is incorrect.",
      "correct_choice_id": 247956,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34652421700221746/34652421700221746.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/34652421700221746/34652421700221746.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83893,
      "choices": [
        {
          "id": 247958,
          "text": "Astemizole"
        },
        {
          "id": 247959,
          "text": "Levocetrizine"
        },
        {
          "id": 247960,
          "text": "Loratidine"
        },
        {
          "id": 247961,
          "text": "Promethazine"
        }
      ],
      "text": "All of the following antihistaminic agents lack anticholinergic property except",
      "unique_key": "Q3403097",
      "question_audio": null,
      "question_video": null,
      "map_id": 34116539,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Promethazine Promethazine is a first-generation antihistamine that has strong anticholinergic properties in addition to its H1 receptor-blocking effects. It is known to block muscarinic receptors, leading to anticholinergic side effects such as dry mouth, blurred vision, urinary retention, constipation, and sedation. Due to its CNS penetration, it also causes significant sedation and is sometimes used for motion sickness and nausea. Incorrect Options (Lack Anticholinergic Properties): (A) Astemizole: Astemizole is a second-generation antihistamine that is highly selective for peripheral H1 receptors and does not have significant anticholinergic properties. It does not cross the blood-brain barrier (BBB) significantly and does not cause sedation or typical antimuscarinic effects. (B) Levocetirizine: Levocetirizine, an active enantiomer of cetirizine, is a second-generation H1 antihistamine with minimal CNS penetration and no significant anticholinergic activity. It is mainly used for allergic rhinitis and urticaria, without causing dry mouth or other muscarinic effects. (C) Loratadine: Loratadine is also a second-generation antihistamine with high selectivity for peripheral H1 receptors and no anticholinergic effects. It is non-sedating and does not cause blurred vision, dry mouth, or urinary retention, making it a safe option for allergy treatment without central or autonomic side effects.",
      "correct_choice_id": 247961,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55345371700221758/55345371700221758.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/55345371700221758/55345371700221758.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83894,
      "choices": [
        {
          "id": 247962,
          "text": "Aspirin"
        },
        {
          "id": 247963,
          "text": "Morphine"
        },
        {
          "id": 247964,
          "text": "Procaine"
        },
        {
          "id": 247965,
          "text": "Sulfadiazine"
        }
      ],
      "text": "Which of the following drugs can cause hypotension by release of histamine from mast cells?",
      "unique_key": "Q1876234",
      "question_audio": null,
      "question_video": null,
      "map_id": 34569304,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Morphine Morphine is an opioid analgesic that can cause hypotension due to histamine release from mast cells. This non-immunologic histamine release leads to vasodilation, flushing, itching, and hypotension. Morphine-induced vasodilation can result in a drop in blood pressure, particularly in high doses or rapid IV administration. This effect is not mediated by opioid receptors, but rather by direct activation of mast cells, leading to histamine release. Incorrect Options: (A) Aspirin: Aspirin is a non-steroidal anti-inflammatory drug (NSAID) that primarily works by inhibiting cyclooxygenase (COX-1 and COX-2), reducing prostaglandin synthesis. It does not cause significant histamine release from mast cells, and its primary cardiovascular effects are related to platelet inhibition and gastric irritation, rather than histamine-mediated hypotension. (C) Procaine: Procaine is a local anesthetic that blocks sodium channels, preventing nerve conduction. While some local anesthetics (especially ester-type like procaine) can rarely trigger allergic reactions, they do not directly cause mast cell degranulation or histamine-mediated hypotension in the same way as morphine. (D) Sulfadiazine: Sulfadiazine is a sulfonamide antibiotic, used primarily for bacterial infections and in combination with pyrimethamine for toxoplasmosis. While sulfonamides can trigger allergic reactions, their mechanism does not involve direct histamine release from mast cells leading to hypotension.",
      "correct_choice_id": 247963,
      "solution_audio": null,
      "solution_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/610911700221771/610911700221771.m3u8",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "https://d2enu63wt1sf3u.cloudfront.net/dqb_vod/610911700221771/610911700221771.m3u8",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83895,
      "choices": [
        {
          "id": 247966,
          "text": "Fexofenadine"
        },
        {
          "id": 247967,
          "text": "Desloratidine"
        },
        {
          "id": 247968,
          "text": "Levocetrizine"
        },
        {
          "id": 247969,
          "text": "Cinnarizine"
        }
      ],
      "text": "The non – sedative antihistaminic are all EXCEPT one",
      "unique_key": "Q3465088",
      "question_audio": null,
      "question_video": null,
      "map_id": 34926338,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Cinnarizine Cinnarizine is a first-generation antihistamine that has significant sedative effects due to its ability to cross the blood-brain barrier (BBB) and block central H1 receptors. Additionally, it has calcium channel-blocking properties, making it useful for treating motion sickness, vertigo, and vestibular disorders. However, its sedative action limits its use as a non-sedative antihistaminic. Incorrect Options: (A) Fexofenadine: Fexofenadine is a second-generation H1 antihistamine that does not cross the BBB significantly, making it non-sedative. It is commonly used to treat allergic rhinitis and urticaria without causing drowsiness. (B) Desloratadine: Desloratadine, a metabolite of loratadine, is another second-generation H1 antihistamine with minimal CNS penetration, resulting in no significant sedation. It is commonly used for allergic conditions like hay fever and chronic idiopathic urticaria. (C) Levocetirizine: Levocetirizine, an active enantiomer of cetirizine, is a second-generation antihistamine with lower sedative effects than first-generation antihistamines. While it may cause mild drowsiness in some individuals, it is still classified as a non-sedative antihistamine.",
      "correct_choice_id": 247969,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83896,
      "choices": [
        {
          "id": 247970,
          "text": "Fexofenadine"
        },
        {
          "id": 247971,
          "text": "Diphenhydramine"
        },
        {
          "id": 247972,
          "text": "Cromolyn sodium"
        },
        {
          "id": 247973,
          "text": "Ranitidine"
        }
      ],
      "text": "A 60-year-old male patient with chronic heart failure is prescribed a medication that acts by inhibiting the release of histamine from mast cells. Which of the following drugs is most likely being used in this patient?",
      "unique_key": "Q1940960",
      "question_audio": null,
      "question_video": null,
      "map_id": 34653569,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Cromolyn Sodium Cromolyn sodium is a mast cell stabilizer that works by inhibiting the release of histamine and other inflammatory mediators from mast cells. It is commonly used for asthma prophylaxis, allergic rhinitis, and allergic conjunctivitis, but it can also be beneficial in patients with chronic heart failure (CHF) due to its anti-inflammatory properties. Inflammation and histamine release can contribute to endothelial dysfunction and increased vascular permeability, worsening heart failure. By preventing histamine release, cromolyn sodium reduces inflammation and stabilizes mast cells, potentially improving cardiovascular function in CHF patients. Incorrect Options: (A) Fexofenadine: Fexofenadine is a second-generation H1 antihistamine used to treat allergic conditions like hay fever and chronic urticaria. However, it does not inhibit histamine release from mast cells—it only blocks H1 receptors to prevent histamine's effects. It has no direct role in managing CHF. (B) Diphenhydramine: Diphenhydramine is a first-generation H1 antihistamine that has sedative and anticholinergic properties. It is not a mast cell stabilizer and does not prevent histamine release. Additionally, it can cause drowsiness and cardiac side effects (such as QT prolongation and arrhythmias), making it unsuitable for CHF patients. (D) Ranitidine: Ranitidine is a histamine H2 receptor antagonist that reduces gastric acid secretion, mainly used for conditions like peptic ulcers and gastroesophageal reflux disease (GERD). It does not stabilize mast cells or prevent histamine release, making it irrelevant in this scenario.",
      "correct_choice_id": 247972,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83897,
      "choices": [
        {
          "id": 247974,
          "text": "Omeprazole"
        },
        {
          "id": 247975,
          "text": "Ranitidine"
        },
        {
          "id": 247976,
          "text": "Diphenhydramine"
        },
        {
          "id": 247977,
          "text": "Famotidine"
        }
      ],
      "text": "A 40-year-old man with a history of peptic ulcer disease is prescribed a medication that acts as an antagonist of H2 receptors in the stomach. Which of the following medications is he most likely prescribed?",
      "unique_key": "Q9170445",
      "question_audio": null,
      "question_video": null,
      "map_id": 34699688,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Ranitidine Ranitidine is a histamine H2 receptor antagonist that works by blocking H2 receptors in the gastric parietal cells, thereby reducing gastric acid secretion. It is commonly prescribed for conditions such as peptic ulcer disease (PUD), gastroesophageal reflux disease (GERD), and Zollinger-Ellison syndrome. By decreasing acid production, ranitidine promotes ulcer healing and helps prevent ulcer recurrence. Incorrect Options: (A) Omeprazole: Omeprazole is a proton pump inhibitor (PPI) that irreversibly inhibits the H+/K+ ATPase enzyme in gastric parietal cells, leading to a more profound reduction in acid secretion compared to H2 blockers. While PPIs like omeprazole are often preferred for long-term management of peptic ulcers, the question specifically asks for an H2 receptor antagonist, making ranitidine the correct choice. (C) Diphenhydramine: Diphenhydramine is a first-generation H1 antihistamine, primarily used for allergic reactions, motion sickness, and sleep aid. It does not affect H2 receptors or gastric acid secretion, making it ineffective for peptic ulcer disease. (D) Famotidine: Famotidine is another H2 receptor antagonist, similar to ranitidine. However, the correct answer is ranitidine because it was more commonly used historically. Due to concerns about potential carcinogenic impurities (NDMA contamination) in ranitidine, famotidine is now preferred in clinical practice.",
      "correct_choice_id": 247975,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83898,
      "choices": [
        {
          "id": 247978,
          "text": "Levocetirizine"
        },
        {
          "id": 247979,
          "text": "Cetirizine"
        },
        {
          "id": 247980,
          "text": "Diphenhydramine"
        },
        {
          "id": 247981,
          "text": "Fexofenadine"
        }
      ],
      "text": "A patient with asthma is prescribed a medication that selectively inhibits the binding of histamine to H1 receptors. Which of the following drugs fits this description?",
      "unique_key": "Q4950204",
      "question_audio": null,
      "question_video": null,
      "map_id": 34809911,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (D) Fexofenadine Fexofenadine is a second-generation H1 receptor antagonist that selectively inhibits the binding of histamine to H1 receptors. It is primarily used to manage allergic conditions such as allergic rhinitis and chronic urticaria. Unlike first-generation antihistamines, fexofenadine does not cross the blood-brain barrier significantly, making it non-sedative and safer for long-term use, especially in patients with respiratory conditions like asthma. Although H1 blockers are not the primary treatment for asthma, second-generation antihistamines like fexofenadine can help control allergic triggers that may worsen asthma symptoms. Incorrect Options: (A) Levocetirizine: Levocetirizine is also a second-generation H1 receptor antagonist, similar to fexofenadine. However, it has more central nervous system (CNS) penetration than fexofenadine, leading to a slightly higher risk of sedation. While it can be used for allergic rhinitis and urticaria, fexofenadine is preferred for asthma patients due to its better safety profile and lower risk of drowsiness. (B) Cetirizine: Cetirizine, the parent drug of levocetirizine, is another second-generation H1 antagonist but has a slightly higher sedative effect compared to fexofenadine. It is effective for allergies but is not the best choice for asthma patients due to its mild CNS effects. (C) Diphenhydramine: Diphenhydramine is a first-generation H1 receptor antagonist that crosses the blood-brain barrier and causes significant sedation and anticholinergic effects. It is mainly used for motion sickness, insomnia, and allergic reactions, but it is not ideal for asthma patients, as it may thicken bronchial secretions and cause drowsiness.",
      "correct_choice_id": 247981,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83899,
      "choices": [
        {
          "id": 247982,
          "text": "Diphenhydramine"
        },
        {
          "id": 247983,
          "text": "Loratadine"
        },
        {
          "id": 247984,
          "text": "Chlorpheniramine"
        },
        {
          "id": 247985,
          "text": "Promethazine"
        }
      ],
      "text": "A 45-year-old man is diagnosed with allergic rhinitis and is prescribed a medication that is a selective H1 antagonist. He is concerned about sedation as he operates heavy machinery. Which of the following medications is least likely to cause sedation?",
      "unique_key": "Q8409700",
      "question_audio": null,
      "question_video": null,
      "map_id": 34985144,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (B) Loratadine Loratadine is a second-generation H1 antihistamine that is highly selective for peripheral H1 receptors and has minimal penetration into the central nervous system (CNS). Unlike first-generation antihistamines, which cross the blood-brain barrier (BBB) and cause sedation, loratadine is non-sedating or causes very minimal drowsiness. Since the patient operates heavy machinery, a non-sedating antihistamine like loratadine is the preferred choice for treating allergic rhinitis, as it effectively reduces symptoms without impairing alertness or motor function. Incorrect Options: (A) Diphenhydramine: Diphenhydramine is a first-generation H1 antihistamine that readily crosses the BBB, leading to significant sedation and drowsiness. It is commonly used for allergic reactions, motion sickness, and as a sleep aid, but it is not suitable for individuals who need to remain alert, such as those operating machinery. (C) Chlorpheniramine: Chlorpheniramine is also a first-generation H1 antihistamine with moderate sedation potential. Although it is less sedating than diphenhydramine or promethazine, it still causes drowsiness and may impair cognitive and motor functions, making it unsuitable for people needing full alertness. (D) Promethazine: Promethazine is a highly sedating first-generation H1 antihistamine with additional anti-dopaminergic and anticholinergic effects. It is commonly used for nausea, motion sickness, and as a sedative, but it can cause profound drowsiness and motor impairment, making it the least suitable option for someone who operates machinery.",
      "correct_choice_id": 247983,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83900,
      "choices": [
        {
          "id": 247986,
          "text": "Diphenhydramine"
        },
        {
          "id": 247987,
          "text": "Cetirizine"
        },
        {
          "id": 247988,
          "text": "Fexofenadine"
        },
        {
          "id": 247989,
          "text": "Promethazine"
        }
      ],
      "text": "A patient experiencing severe allergic symptoms is treated with an antihistamine that does not cross the blood-brain barrier effectively. Which of the following medications fits this description?",
      "unique_key": "Q7449437",
      "question_audio": null,
      "question_video": null,
      "map_id": 34944355,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (C) Fexofenadine Fexofenadine is a second-generation H1 antihistamine that is used to treat severe allergic symptoms such as rhinitis, urticaria, and other hypersensitivity reactions. It is preferred in such cases because: It does not cross the blood-brain barrier (BBB) effectively, due to its low lipid solubility and efflux by P-glycoprotein transporters. As a result, it has minimal sedative effects, making it suitable for patients who need to stay alert (e.g., while driving or working). It selectively blocks peripheral H1 receptors, reducing allergic symptoms without causing drowsiness. Fexofenadine is commonly used for conditions like seasonal allergic rhinitis and chronic urticaria where long-term treatment is needed without sedation. Incorrect Options: (A) Diphenhydramine: Diphenhydramine is a first-generation H1 antihistamine that readily crosses the BBB and has strong sedative effects. It is often used as a sleep aid or for treating motion sickness but is not ideal for patients needing to stay alert. (B) Cetirizine: Cetirizine is a second-generation H1 antihistamine, but it has mild sedative effects because it can cross the BBB to a small extent. While it causes less drowsiness than first-generation antihistamines, it is not as non-sedative as fexofenadine. (D) Promethazine: Promethazine is a first-generation antihistamine that crosses the BBB easily and has strong sedative and anti-nausea effects. It is used for motion sickness, nausea, and vomiting, but it is not ideal for treating allergic reactions in patients who need to remain alert.",
      "correct_choice_id": 247988,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 83901,
      "choices": [
        {
          "id": 247990,
          "text": "Lorcaserin"
        },
        {
          "id": 247991,
          "text": "Orlistat"
        },
        {
          "id": 247992,
          "text": "Naltrexone/bupropion"
        },
        {
          "id": 247993,
          "text": "Liraglutide"
        }
      ],
      "text": "A 50-year-old woman with obesity and a family history of cardiovascular disease is looking for a medication to assist with weight loss. After evaluation, her doctor prescribes a medication that works by reducing appetite and enhancing satiety through serotonin pathways. Which medication did the doctor prescribe?",
      "unique_key": "Q2321238",
      "question_audio": null,
      "question_video": null,
      "map_id": 34941913,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "Correct Answer (A) Lorcaserin Lorcaserin is a selective serotonin 5-HT2C receptor agonist that promotes weight loss by: Suppressing appetite through activation of serotonin receptors in the hypothalamus. Enhancing satiety, leading to reduced caloric intake. Modulating central serotonin pathways, which play a role in food intake and energy balance. Lorcaserin is particularly useful in obese patients with cardiovascular risk factors because it does not significantly raise blood pressure or heart rate, unlike some other weight-loss medications. However, it was withdrawn from the market due to concerns about potential cancer risks, but historically, it was used for weight loss through serotonin modulation. Incorrect Options: (B) Orlistat: Orlistat is a lipase inhibitor that works by blocking fat absorption in the intestine, leading to reduced caloric intake. It does not work via serotonin pathways or appetite suppression. Its main side effects include gastrointestinal disturbances (oily stools, flatulence, fecal urgency). (C) Naltrexone/bupropion: This combination drug works by modulating dopamine and opioid pathways to control food cravings and reduce appetite. While effective for weight loss, it does not primarily act on serotonin pathways, making it an incorrect choice for this question. (D) Liraglutide: Liraglutide is a GLP-1 receptor agonist that reduces appetite and increases satiety. While it is used for weight loss and type 2 diabetes management, it does not act directly on serotonin pathways like lorcaserin.",
      "correct_choice_id": 247990,
      "solution_audio": null,
      "solution_video": "",
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": "",
      "question_images": [],
      "explanation_images": []
    }
  ]
}